Skip to main content
logo
Chiome Bioscience Inc. (TYO:4583)
Japan flag Japan · Delayed Price · Currency is JPY
107.00
-2.00 (-1.83%)
At close: Mar 6, 2026

Chiome Bioscience Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-982.78-1,021-1,220-1,243-1,480
Depreciation & Amortization
3.741.171.21.482.96
Loss (Gain) From Sale of Investments
----150
Other Operating Activities
-0.37-32.467.0522.6922.15
Change in Accounts Receivable
-20.9332.1332.02-89.7631.32
Change in Inventory
-3.2417.947.37-12.4930.21
Change in Accounts Payable
10.25-10.545.872.06-10.3
Change in Unearned Revenue
130.33---4.6-
Change in Other Net Operating Assets
-72.9811.8897.31132.49122.27
Operating Cash Flow
-935.99-1,001-1,069-1,191-1,131
Capital Expenditures
-40.08----
Sale of Property, Plant & Equipment
--0.17--
Other Investing Activities
-15.38----35.38
Investing Cash Flow
-55.46-0.17--35.38
Short-Term Debt Issued
--10713
Long-Term Debt Issued
200----
Total Debt Issued
200-10713
Short-Term Debt Repaid
-194.8-9.5---
Long-Term Debt Repaid
-25----
Total Debt Repaid
-219.8-9.5---
Net Debt Issued (Repaid)
-19.8-9.510713
Issuance of Common Stock
160.031,748560.31,126268.34
Repurchase of Common Stock
-7.03-0.58---
Other Financing Activities
-0-00-00
Financing Cash Flow
133.21,738667.31,127271.35
Miscellaneous Cash Flow Adjustments
-0----
Net Cash Flow
-858.25737.73-401.72-63.72-895.33
Free Cash Flow
-976.07-1,001-1,069-1,191-1,131
Free Cash Flow Margin
-164.52%-128.16%-156.67%-188.81%-158.68%
Free Cash Flow Per Share
-14.38-17.19-21.58-27.08-28.09
Cash Interest Paid
3.162.872.071.321.32
Cash Income Tax Paid
2.535.015.013.24-4.56
Levered Free Cash Flow
-641.7-651.57-630.68-748.1-648.68
Unlevered Free Cash Flow
-639.73-649.78-629.39-747.27-647.86
Change in Working Capital
43.4251.41142.5727.7173.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.